Astera Labs, Inc.
257.16USD
-0.6600 (-0.26%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on ALAB.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 392 | 308 | 271 | 231 | 192 | 159 | 141 | 113 |
| Cost of Revenue | 105 | 73 | 66 | 55 | 46 | 40 | 37 | 25 |
| Gross Profit | 288 | 235 | 204 | 176 | 146 | 119 | 104 | 88 |
| Operating Income | 89 | 62 | 67 | 55 | 40 | 11 | 0 | -9 |
| Net Income | 153 | 80 | 45 | 91 | 51 | 32 | 25 | -8 |
| EPS (Diluted) | $0.83 | $0.44 | $0.25 | $0.50 | $0.29 | $0.18 | $0.25 | -$0.05 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)